Windtree Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 20.29 million compared to USD 39.21 million a year ago. Basic loss per share from continuing operations was USD 94.3199 compared to USD 1,120.1391 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 USD | -1.98% | -10.26% | -72.96% |
May. 15 | Windtree Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 17 | Windtree Therapeutics Seeks Acquisitions | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-72.96% | 1.78M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+38.25% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- WINT Stock
- News Windtree Therapeutics, Inc.
- Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023